Evidence map›Paper›PMID 35116944›Full record

ArticleTranslational cancer research2019

Comparison of liver function and safety in hepatocellular cancer patients treated with DEB-TACE and cTACE: a multi-center, retrospective cohort study.

Hua Xiang, Bin Xiong, Haiping Li, Chang Zhao, Zishu Zhang, Cong Ma, Chuansheng Zheng, Chao Luo, Huaiming Qiu, Yuanhui Yao and 6 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 1 country.

Hua Xiang *Department of Intervention, Hunan Provincial People's Hospital, Changsha 410005, China.
Bin Xiong *Department of Interventional Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Haiping LiDepartment of Radiology, Xiangya Hospital, Central South University, Changsha 410008, China.
Chang ZhaoDepartment of Interventional Therapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, China.
Zishu ZhangDepartment of Radiology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
Cong MaDepartment of Radiology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
Chuansheng ZhengDepartment of Interventional Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Chao LuoDepartment of Radiology, Wuhan General Hospital of Guangzhou Military, Wuhan, China.
Huaiming QiuDepartment of Radiology, Wuhan General Hospital of Guangzhou Military, Wuhan, China.
Yuanhui YaoDepartment of Intervention, Hunan Provincial People's Hospital, Changsha 410005, China.
Hongyao HuDepartment of Radiology, Renmin Hospital of Wuhan University, Hubei General Hospital, Wuhan 430070, China.
Hui ZhaoDepartment of Radiology, Renmin Hospital of Wuhan University, Hubei General Hospital, Wuhan 430070, China.
Qingyun LongDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Jun ZhouDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Changyong ChenDepartment of Radiology, Xiangya Hospital, Central South University, Changsha 410008, China.
Yilong MaDepartment of Interventional Therapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, China.
Wuhan University · CNCentral South University · CNHunan Provincial People's Hospital · CNTumor Hospital of Guangxi Medical University · CNWuhan General Hospital of Guangzhou · CNHuazhong University of Science and Technology · CNSecond Xiangya Hospital of Central South University · CNUnion Hospital · CNXiangya Hospital Central South University · CNZhongnan Hospital of Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to compare the live function change and adverse events (AEs) between drug-eluting beads (DEB) transarterial chemoembolization (TACE) with CalliSpheres

methodsThree hundred and thirty-five HCC patients underwent DEB-TACE with CSM (n=171, DEB-TACE group) or cTACE (n=164, cTACE group) were consecutively enrolled in this multi-center, retrospective cohort study. Liver function indexes were reviewed before treatment (W0), at 1 week (W1) and 1 month (M1) post treatment. Moreover, AEs during operation and hospitalization were retrieved as well.

resultsThe changes of albumin (ALB) [-3.55 (-6.25 to -0.43)

conclusionsDEB-TACE with CSM is non-inferior to cTACE in terms of liver function change, while DEB-TACE with CSM leads to higher incidences of pain and fever.

Indexed as

CalliSpheres® microspheres (CSM)conventional transarterial chemoembolization (cTACE)drug-eluting bead transarterial chemoembolization (DEB-TACE)hepatocellular carcinoma (HCC)liver functionsafety

Identifiers

PMID35116944
PMCPMC8799233
OpenAlexW4238690432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.